Overview
Abrey is a registered Trans-Tasman Patent Attorney in our Chemical & Life Sciences group with a focus on biotechnology. She has experience in drafting and prosecuting patent applications, as well as providing patentability assessments, freedom-to-operate analyses, and advice on infringement and validity within the biotechnology and life sciences sector. Abrey has worked with clients to secure protection for inventions across numerous jurisdictions, including Australia, New Zealand, the United States, Europe, Singapore, Japan, Korea, and other regions globally.
Abrey completed a PhD in Biochemistry and Molecular Biology at the University of Queensland and has over a decade of experience in clinical research.
She served as a Postdoctoral Research Fellow and managed the Cancer and Neuroscience Group at the University of Queensland Centre for Clinical Research (UQCCR). Her work primarily focused on DNA damage and repair and transcription regulation, in the context of diverse clinical conditions—such as neurodegenerative diseases, pulmonary diseases, fibrosis, and sterility—utilising experimental models such as mouse and rat models, patient-derived cellular models including induced pluripotent stem cells (iPSCs)and various cell lines.
Abrey was awarded a Research Fellowship from the Children’s Hospital Foundation and has played a key role in obtaining competitive grant funding totaling approximately AUD $3M from various organisations. She has also published over 30 peer-reviewed articles in the top 10% of journals in the field. Notably, her research led to the development of a novel anaplerotic approach to alleviate metabolic stress and restore mitochondrial function in patients with Ataxia-telangiectasia, with significantly improved clinical outcomes demonstrated through a Phase 2A/B clinical trial.